{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:23:48Z","timestamp":1791393828647,"version":"4.3.3"},"reference-count":38,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T00:00:00Z","timestamp":1217376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background\u2002<\/jats:bold>\n                    The intestinal permeability is increased in patients with diarrhoea\u2010predominant irritable bowel syndrome (D\u2010IBS).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Aim\u2002<\/jats:bold>\n                    To determine the possible efficacy of lactic acid bacteria on the increased intestinal permeability in D\u2010IBS.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods\u2002<\/jats:bold>\n                    Treatment was employed for 4\u2003weeks in a randomized single blind placebo controlled study with 30 D\u2010IBS patients. Patients were given either probiotic fermented milk (\n                    <jats:italic>Streptococcus thermophilus<\/jats:italic>\n                    ,\n                    <jats:italic>Lactobacillus bulgaricus<\/jats:italic>\n                    ,\n                    <jats:italic>Lactobacillus acidophilus<\/jats:italic>\n                    and\n                    <jats:italic>Bifidobacterium Longum<\/jats:italic>\n                    ) or milk beverage containing no bacteria. The clinical symptoms were scored and intestinal permeability was measured by a triple sugar test before and after treatment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2002<\/jats:bold>\n                    Small bowel permeability was measured as the ratio of lactulose and mannitol recovery and colonic permeability was measured as the total mass of sucralose excretion (mg). After probiotics treatment, small bowel permeability decreased significantly from 0.038 (0.024) at baseline to 0.023 (0.020) (\n                    <jats:italic>P\u2003<\/jats:italic>\n                    =\n                    <jats:italic>\u2003<\/jats:italic>\n                    0.004), the proportion of patients with increased small bowel permeability was lower than baseline (28.6% vs. 64.3%,\n                    <jats:italic>P\u2003<\/jats:italic>\n                    =\n                    <jats:italic>\u2003<\/jats:italic>\n                    0.023). However, colonic permeability improved neither in the probiotics group nor in the placebo group at week 4. Treatment with probiotics significantly decreased the mean global IBS scores compared with the baseline scores (9.62\u2003\u00b1\u20031.05 vs. 7.64\u2003\u00b1\u20031.24,\n                    <jats:italic>P\u2003<\/jats:italic>\n                    &lt;\n                    <jats:italic>\u2003<\/jats:italic>\n                    0.001).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion\u2002<\/jats:bold>\n                    Short\u2010term active lactic acid bacteria treatment for D\u2010IBS improved mucosal barrier function.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2036.2008.03818.x","type":"journal-article","created":{"date-parts":[[2008,9,20]],"date-time":"2008-09-20T06:11:28Z","timestamp":1221891088000},"page":"994-1002","source":"Crossref","is-referenced-by-count":156,"title":["Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea\u2010predominant irritable bowel syndrome"],"prefix":"10.1111","volume":"28","author":[{"given":"J.","family":"ZENG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.\u2010Q.","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.\u2010L.","family":"ZUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.\u2010B.","family":"ZHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.\u2010H.","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.6.804"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00672.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02284.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00667.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33579"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.11.055"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.37059"},{"key":"e_1_2_6_9_2","first-page":"A136","article-title":"Distinctive histological patterns of chronic inflammatory cells in rectal biopsies of patients with different clinical subtypes of IBS","volume":"122","author":"Dunlop SP","year":"2002","journal-title":"Gastroenterology"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2005.00685.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1998.274.1.F1"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7599"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01640.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.147.3659.747"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2003.008664"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/130.2.396S"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-007-0048-6"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01543.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.050"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03362.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03542.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01535722"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.5.650"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/clinchem\/41.5.752","article-title":"Rapid gas\u2010chromatographic assay of lactulose and mannitol for estimating intestinal permeability","volume":"41","author":"Celli M","year":"1995","journal-title":"Clin Chem"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1570-0232(02)00787-0"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0867"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2006.03.014"},{"key":"e_1_2_6_28_2","volume-title":"The Effect of Lactobacillus plantarum Species 299 on Intestinal Inflammation and Associated Gut Mucosal Barrier Dysfunction","author":"Kennedy RJ","year":"2000"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.27224"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0219"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.6.3686-3692.2005"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2003.12.002"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2004.08.008"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00265.2006"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.6.827"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2006.00836.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001308"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)83122-3"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.2001.281.1.G216"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2008.03818.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2008.03818.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:40:55Z","timestamp":1697197255000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2008.03818.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,20]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1365-2036.2008.03818.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03818.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1121748.578817","asserted-by":"object"}]},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,20]]}}}